RPG Life Sciences Limited (RPGLIFE.BO)
- Previous Close
1,548.35 - Open
1,551.05 - Bid --
- Ask --
- Day's Range
1,544.70 - 1,580.00 - 52 Week Range
745.00 - 1,740.00 - Volume
1,274 - Avg. Volume
1,410 - Market Cap (intraday)
25.932B - Beta (5Y Monthly) 0.49
- PE Ratio (TTM)
30.59 - EPS (TTM)
51.25 - Earnings Date Apr 30, 2024
- Forward Dividend & Yield 12.00 (0.78%)
- Ex-Dividend Date Jul 21, 2023
- 1y Target Est
547.00
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies. It operates in nephrology, rheumatology, oncology, gastroenterology, cardiovascular, orthopedics, respiratory, neurology, general, urology, anti-diabetic, anti-dengue, vitamins and minerals, gynecology, pediatrics, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
www.rpglifesciences.com1,214
Full Time Employees
March 31
Fiscal Year Ends
Sector
Related News
Performance Overview: RPGLIFE.BO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RPGLIFE.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RPGLIFE.BO
Valuation Measures
Market Cap
25.61B
Enterprise Value
24.58B
Trailing P/E
30.21
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.49
Price/Book (mrq)
7.63
Enterprise Value/Revenue
4.31
Enterprise Value/EBITDA
18.80
Financial Highlights
Profitability and Income Statement
Profit Margin
14.78%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
5.74B
Net Income Avi to Common (ttm)
847.7M
Diluted EPS (ttm)
51.25
Balance Sheet and Cash Flow
Total Cash (mrq)
1.02B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Research Analysis: RPGLIFE.BO
Company Insights: RPGLIFE.BO
RPGLIFE.BO does not have Company Insights